Company Performance: Revenue growth, profitability, and successful drug launches typically drive the stock price higher. Conversely, poor earnings, clinical trial failures, or regulatory setbacks can negatively impact it.

Pharmaceutical Industry Trends: Changes in healthcare policy, patent expirations, and the emergence of new technologies within the pharmaceutical sector can all influence investor sentiment towards BHC.TO.

Market Conditions: Broader market trends, such as economic growth, interest rate changes, and investor risk appetite, can affect the demand for stocks in general, including BHC.TO.

Debt Levels: High levels of debt, like those historically carried by Bausch Health, can make investors cautious and limit the company's financial flexibility. Debt reduction efforts can be a positive signal.

Regulatory Environment: Government regulations related to drug pricing, approval processes, and intellectual property protection have a significant impact on the pharmaceutical industry and BHC.TO.

Competition: The presence of competing products, generic drug availability, and the intensity of competition within specific therapeutic areas can affect Bausch Health's market share and profitability.

Legal and Litigation Risks: Ongoing or potential lawsuits, regulatory investigations, and product liability claims can create uncertainty and negatively influence the stock price.

Management and Strategy: Investor confidence in the management team's ability to execute the company's strategic plan and make sound business decisions is crucial for a positive stock performance.

Global Economic Factors: Global economic conditions, currency fluctuations, and international healthcare trends influence Bausch Health's operations and revenue streams, especially since they operate internationally.

Investor Sentiment: Overall market sentiment and investor perception of Bausch Health's future prospects also play a role. News coverage, analyst ratings, and social media discussions can influence investor behavior.